What does a tissue transglutaminase antibody (tTGA) Immunoglobulin A (IgA) level of less than 1.02 indicate in a patient with suspected celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Tissue Transglutaminase IgA Result

A tTG IgA level of <1.02 is negative and effectively rules out celiac disease in patients consuming adequate gluten, indicating no further celiac-specific workup is needed. 1

Interpretation of the Result

  • This result is well below the diagnostic threshold (typically 4-20 U/mL depending on the assay) and falls within the normal reference range, indicating absence of celiac disease antibodies. 2

  • The negative tTG IgA has a negative predictive value approaching 100% when the patient has been consuming adequate gluten (at least 10g daily for 6-8 weeks prior to testing). 1, 3

  • In adults, tTG IgA demonstrates 90.7% sensitivity and 87.4% specificity at standard diagnostic thresholds, making it highly reliable for excluding celiac disease when negative. 4

Clinical Significance

  • No celiac disease is present based on this serologic result, assuming the patient was consuming a normal gluten-containing diet at the time of testing. 1

  • This result confirms that IgA-based antibody tests are valid (assuming total IgA was measured and is normal), as the test is functioning properly to detect antibodies if they were present. 1

  • Approximately 2-10% of patients with actual celiac disease could theoretically have false-negative results, but this occurs primarily in patients who have already reduced gluten intake or have very early/mild disease. 1

Important Caveats

  • The patient must have been consuming adequate gluten (at least 10g daily for 6-8 weeks) before testing to avoid false-negative results. 1, 5

  • Total IgA levels should be measured concurrently to rule out selective IgA deficiency (occurs in 1-3% of celiac patients), which would cause falsely negative IgA-based antibody tests. 4, 1

  • If IgA deficiency is present, IgG-based testing (IgG deamidated gliadin peptide or IgG tTG) must be performed instead, as IgA tests are unreliable in this population. 4, 1

When to Pursue Further Testing Despite Negative Result

  • Proceed to upper endoscopy with duodenal biopsies if clinical suspicion remains very high despite negative serology (chronic diarrhea, weight loss, malabsorption, family history). 1, 5

  • Consider HLA-DQ2/DQ8 genetic testing if seronegative celiac disease is suspected—absence of both alleles has >99% negative predictive value and essentially rules out celiac disease. 1, 5

  • Repeat testing after ensuring adequate gluten consumption if the patient had reduced gluten intake before the initial test. 1

Next Steps

  • No gluten-free diet should be initiated based on symptoms alone without confirmed celiac disease, as this can lead to nutritional deficiencies and unnecessary dietary restrictions. 1

  • Consider alternative diagnoses for gastrointestinal symptoms, such as irritable bowel syndrome, inflammatory bowel disease, or non-celiac gluten sensitivity. 1

  • Repeat celiac screening may be warranted in high-risk populations (type 1 diabetes, first-degree relatives of celiac patients, autoimmune thyroid disease) if new symptoms develop, even with previously negative serology. 4, 1

References

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Celiac Disease with Positive IgA but Negative Anti-TTG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.